Literature DB >> 6566603

Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.

B Nardelli, P Puccetti, L Romani, G Sava, E Bonmassar, M C Fioretti.   

Abstract

Equitoxic doses of 5-(3-3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) and aryl-triazene derivatives (compounds all capable of inducing a marked increase in murine tumor cell immunogenicity) were studied for their effects on the host immune system. At different times after drug exposure the animals were tested for allograft responses, competence in producing lymphocytes active in lethal graft-versus-host disease, delayed-type hypersensitivity, humoral antibody production, and mitogen responsiveness. While some of the aryl-triazenes tested (DM-COOK DM-NO2) showed a pattern of immunodepression similar to that of DTIC, others were less (MIC, MM-COOK, MM-Cl) or far less (DM-Cl, MM-NO2) active than DTIC in impairing host immunocompetence, although all retained or even augmented their ability to induce chemical xenogenization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6566603     DOI: 10.1007/bf00205488

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  12 in total

1.  Synthesis of 2-arylfurans.

Authors:  A W JOHNSON
Journal:  J Chem Soc       Date:  1946-10

2.  Effects of variation in time and dose of cyclophosphamide injection on delayed hypersensitivity and antibody formation.

Authors:  J A Kerckhaert; F M Hofhuis; J M Willers
Journal:  Cell Immunol       Date:  1977-03-15       Impact factor: 4.868

Review 3.  Plaque forming cells: methodology and theory.

Authors:  N K Jerne; C Henry; A A Nordin; H Fuji; A M Koros; I Lefkovits
Journal:  Transplant Rev       Date:  1974

4.  Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.

Authors:  E Bonmassar; A Bonmassar; S Vadlamudi; A Goldin
Journal:  Cancer Res       Date:  1972-07       Impact factor: 12.701

5.  Synthesis of biologically active triazenes from isolable diazoniums salts.

Authors:  G F Kolar
Journal:  Z Naturforsch B       Date:  1972-10       Impact factor: 1.047

6.  Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.

Authors:  R B Herberman; T Aoki; M Nunn; D H Lavrin; N Soares; A Gazdar; H Holden; K S Chang
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

7.  Drug-mediated changes of tumour cell immunogenicity and antigenicity.

Authors:  P Puccetti; L Romani; D Taramelli; E Bonmassar; M C Fioretti
Journal:  Int J Tissue React       Date:  1982

8.  Long-term depression of two primary immune responses induced by a single dose of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC).

Authors:  P Puccetti; A Giampietri; M C Fioretti
Journal:  Experientia       Date:  1978-06-15

9.  Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.

Authors:  A Giampietri; A Bonmassar; P Puccetti; A Circolo; A Goldin; E Bonmassar
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

View more
  5 in total

1.  Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative.

Authors:  M Allegrucci; P Fuschiotti; P Puccetti; L Romani; M C Fioretti
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

2.  Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.

Authors:  G Sava; S Zorzet; L Perissin; S Pacor; L Lassiani; C Nisi; A Varnavas
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 3.  Chemical xenogenization of experimental tumors.

Authors:  P Puccetti; L Romani; M C Fioretti
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Effects of prolonged treatment with decarbazine on tumor metastatic potential in mice bearing Lewis lung carcinoma.

Authors:  S Zorzet; L Perissin; V Rapozzi; S Pacor; T Giraldi
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

Review 5.  Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.

Authors:  Ornella Franzese; Francesco Torino; Maria Pia Fuggetta; Angelo Aquino; Mario Roselli; Enzo Bonmassar; Anna Giuliani; Stefania D'Atri
Journal:  Oncotarget       Date:  2017-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.